Innovations in regenerative medicine and stem cell therapy for diabetes offer hope for restoring insulin production and reversing disease progression. Stem cell-derived beta-cell transplants are being developed to replace damaged pancreatic cells, providing a potential cure for type 1 diabetes. Advances in tissue engineering and gene editing technologies, such as CRISPR, enable the creation of personalized regenerative therapies. Encapsulation techniques protect transplanted cells from immune attack, enhancing long-term viability. While challenges remain in achieving sustained insulin secretion and immune tolerance, ongoing clinical trials are bringing regenerative medicine closer to clinical application. These breakthroughs could revolutionize diabetes treatment, reducing dependence on insulin therapy
Mahir Khalil Ibrahim Jallo
Gulf Medical University, Canada
Yong Xiao Wang
Albany Medical College, United States
F Buck Willis
Christian College of Medicine, Belize
Sujith Rajan
NYU Long Island School of Medicine, United States
Amy Gutman
AdventHealth; Tough Love MD, United States
Anil Harrison
Midwestern University, United States
Jun Dai
Des Moines University, United StatesSubmit your abstract Today
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, Christian College of Medicine, Belize
Title : Important roles and mechanisms of novel calcium signaling in diabetes-induced vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Post transplant diabetes mellitus: Advances and innovations
Kurtis J Swanson, University of Wisconsin-Madison School of Medicine and Public Health, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters ?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : The menopausal mind: Reframing female senescence as a neuroendocrine disorder with root cause management strategies
Amy Gutman, AdventHealth; Tough Love MD, United States